We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene.
- Authors
Zhang, Weidong; Yang, Hong; Kong, Xiaoyuan; Mohapatra, Subhra; Juan-Vergara, Homero San; Hellermann, Gary; Behera, Sumita; Singam, Rajeswari; Lockey, Richard F; Mohapatra, Shyam S
- Abstract
Respiratory syncytial virus (RSV) infection is one of the major causes of respiratory tract infection for which no vaccine or antiviral treatment is available. The RSV NS1 protein seems to antagonize the host interferon (IFN) response; however, its mechanism is unknown. Here, we used a plasmid-borne small interfering RNA targeting the NS1 gene (siNS1) to examine the role of NS1 in modulating RSV infection. RSV replication was reduced in A549 cells, but not IFN-deficient Vero cells, transfected with siNS1. siNS1 induced upregulated expression of IFN-ßand IFN-inducible genes in A549 cells. siNS1-transfected human dendritic cells, upon RSV infection, produced elevated type-1 IFN and induced differentiation of naive CD4+ T cells to T helper type 1 (TH1) cells. Mice treated intranasally with siNS1 nanoparticles before or after infection with RSV showed substantially decreased virus titers in the lung and decreased inflammation and airway reactivity compared to controls. Thus, siNS1 nanoparticles may provide an effective inhibition of RSV infection in humans.
- Subjects
PARAMYXOVIRUSES; RESPIRATORY syncytial virus; VIRUS diseases; PREVENTIVE medicine; ANTINEOPLASTIC agents; ANTIVIRAL agents
- Publication
Nature Medicine, 2005, Vol 11, Issue 1, p56
- ISSN
1078-8956
- Publication type
Article
- DOI
10.1038/nm1174